A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
Genetically Modified Primary Cells for Allogeneic Cell Therapy
Publication Number: US20240010988A1 Filing Date: August 11, 2022 (Priority via provisional filings) Publication Date: January 11, 2024 (this application remains active into 2025) Assignee / Applicant: Sana Biotechnology, Inc. Inventors: Sonja Schrepfer, Xiaomeng Hu, et…
-
Recombinant Antibodies and Uses Thereof
Publication No.: WO 2025 058631 A1Publication Date: March 20, 2025Filing (Priority) Date: September 17, 2023 (PCT/US2023/032971)Jurisdiction: International (PCT publication; can enter national phases)Tech Field: Recombinant antibody therapeutics What This Patent Application Covers This patent application describes recombinant antibodies and their uses, including…
-
Internal cap-initiated translation for efficient protein production from circular mRNA
Published in Nature Biotechnology (February 19, 2025) — this study introduces a novel internal cap-initiated mechanism that significantly enhances the efficiency of protein production from circular mRNA therapeutics. What it covers Traditionally, circular mRNAs —…
